Charles A. Stanley, MD
Areas of expertise: Research in hyperinsulinism
Locations: Main Building
About Charles A. Stanley, MD
Charles A. Stanley, MD, is founder of the Congenital Hyperinsulinism Center at the Children's Hospital of Philadelphia and Professor Emeritus of Pediatrics at the University of Pennsylvania Perelman School of Medicine. He is a past-president of the Pediatric Endocrine Society (formerly named in honor of Lawson Wilkins).
Dr. Stanley is a world-renowned expert on hypoglycemia in children, including glycogen storage diseases, fatty acid oxidation defects, and disorders of insulin regulation. He has helped define the various types of congenital hyperinsulinism (HI) and pioneered best practices for diagnosis and treatment of congenital HI.
Research into the genetic causes of HI (hypoglycemia caused by high levels of insulin in the blood) is an area Dr. Stanley is particularly passionate about. His laboratory is currently supported by a prestigious MERIT award from the NIH.
“Genetic diagnosis will enable physicians to determine with greater accuracy and speed which babies have the best chance of cure by surgical treatment,” he says.
Under Dr. Stanley’s mentorship, researchers were able to identify specific mutations in GLUD1, the gene that causes the hyperinsulinism/hyperammonemia (HI/HA) syndrome.
Under Dr. Stanley’s direction, CHOP’s HI program became one of few in the world that offers qualified patients a special positron emission tomography (PET) scan under research protocols. The 18F-DOPA PET scan helps the medical team distinguish between diffuse HI (spread throughout the pancreas) or focal HI (concentrated in one spot). For children with focal HI, the scan acts as a roadmap which allows the surgeon to remove only the affected part of the pancreas and to cure a child’s hyperinsulinism while minimizing the chance of diabetes.
Dr. Stanley has published numerous articles in journals such as The New England Journal of Medicine, Journal of Pediatrics, Diabetes, Journal of Clinical Endocrinology and Metabolism, and The Journal of Biological Chemistry. He was recently co-editor of Monogenic Hyperinsulinemic Hypoglycemia Disorders, volume 21 of “Frontiers in Diabetes.” Additionally, Dr. Stanley has served as an editorial board member, guest editor and reviewer for more than a dozen medical journals.
In conjunction with his published work, Dr. Stanley has also lectured extensively around the world about the causes and treatment of congenital hyperinsulinism and hypoglycemia (low blood sugar) in neonates and young children. He coordinated two international symposia where thought-leaders converged in Philadelphia to share their research and develop collaborations in the area of congenital hyperinsulinism and monogenic forms of diabetes.
Dr. Stanley earned his bachelor's degree in biochemical sciences from Harvard University, Cambridge, MA, and his medical degree from the University of Virginia School of Medicine, Charlottesville, VA. He completed his residency in pediatrics and a fellowship in metabolic diseases and endocrinology, both at Children’s Hospital of Philadelphia, Philadelphia, PA.
Titles
Pediatric Endocrinologist
Emeritus Professor CE of Pediatrics, Perelman School of Medicine at the University of Pennsylvania
Certifications
Pediatric Endocrinology – American Board of Pediatrics
Pediatrics – American Board of Pediatrics
Editorial and Academic Positions
Editorial Positions
2013-present, FDA Endocrinology Metabolism Diabetes Advisory Committee
1994-present, NIH Medical Biochemistry Study Section, Ad Hoc Reviewer
1986-present, NIH Site Visitor, GCRC, Cincinnati
1985-present, NIH Site Visitor, GCRC, Cleveland
1983-present, NIH Site Visitor, GCRC, Duke University
1981-present, NICHD Site Visitor, Cleveland, Ohio
Associate Editor, Diabetes
Academic and Institutional Committees
1985-present, GCRC Advisory Committee (Ex officio)
2000-present, DERC Executive Committee
Education & training
Medical Degree
MD - University of Virginia School of Medicine, Charlottesville, VA
Residency
Pediatrics - The Children's Hospital of Philadelphia, Philadelphia, PA
Fellowship
Metabolic Diseases - The Children's Hospital of Philadelphia, Philadelphia, PA
Publications
Publications
2018
Gibson CE, Boodhansingh KE, Li C, Conlin L, Chen P, Becker S, Adzick NS, Bamba V, De Leon DD, Ganguly A, Stanley CA: Congenital hyperinsulinism in Infants with Turner Syndrome: Possible association with Monosomy X and KDM6A haploinsufficiency. Hormone Research in Pediatrics 89:413-422, 2018.
Adzick NS, De Leon DD, States LJ, Lord K, Bhatti TR, Becker SA, Stanley CA. Surgical treatment of congenital hyperinsulinism: Results from 500 pancreatectomies in neonates and children. J Pediatr Surg. 2019 Jan;54(1):27-32. doi: 10.1016/j.jpedsurg.2018.10.030. Epub 2018 Oct 5.
2017
Ferrara CT, Boodhansingh KE, Paradies E, Giuseppe F, Steinkrauss LJ, Topor LS, Quintos JB, Ganguly A, De León DD, Palmieri F, Stanley CA. Novel hypoglycemia phenotype in congenital hyperinsulinism due to dominant mutations of uncoupling protein 2. J Clin Endocrinol Metab. 2017 Mar 1;102(3):942-949. doi: 10.1210/jc.2016-3164.
Barrosse-Antle M, Su C, Chen P, Boodhansingh KE, Smith TJ, Stanley CA, De León DD, Li C. A severe case of hyperinsulinism due to hemizygous activating mutation of glutamate dehydrogenase. Pediatr Diabetes. 2017 Feb 6. doi: 10.1111/pedi.12507.
De León DD, Stanley CA. Congenital hypoglycemia disorders: new aspects of etiology, diagnosis, treatment and outcomes: Highlights of the Proceedings of the Congenital Hypoglycemia Disorders Symposium, Philadelphia April 2016. Pediatr Diabetes. 2017 Feb;18(1):3-9. doi: 10.1111/pedi.12453. Epub 2016 Oct 18.
2016
Martin GM, Rex EA, Devaraneni P, Denton JS, Boodhansingh KE, De León DD, Stanley CA, Shyng SL. Pharmacological Correction of Trafficking Defects in ATP-sensitive Potassium Channels Caused by Sulfonylurea Receptor 1 Mutations. J Biol Chem. 2016 Oct 14;291(42):21971-21983. Epub 2016 Aug 29.
Wong SY, Beamer LJ, Gadomski T, Honzik T, Mohamed M, Wortmann SB, Brocke Holmefjord KS, Mork M, Bowling F, Sykut-Cegielska J, Koch D, Ackermann A, Stanley CA, Rymen D, Zeharia A, Al-Sayed M, Marquardt T, Jaeken J, Lefeber D, Conrad DF, Kozicz T, Morava E. Defining the phenotype and assessing severity in phosphoglucomutase-1 deficiency. J Pediatr. 2016 Aug;175:130-136.e8. doi: 10.1016/j.jpeds.2016.04.021. Epub 2016 May 17.
Stanley CA. Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders. J Clin Endocrinol Metab. 2016 Mar;101(3):815-26. doi: 10.1210/jc.2015-3651. Epub 2016 Feb 23.
Kalish JM, Boodhansingh KE, Bhatti TR, Ganguly A, Conlin LK, Becker SA, Givler S, Mighion L, Palladino AA, Adzick NS, De León DD, Stanley CA,
Deardorff MA. Congenital hyperinsulinism in children with paternal 11p uniparental isodisomy and Beckwith-Wiedemann syndrome. J Med Genet. 2016 Jan;53(1):53-61. doi: 10.1136/jmedgenet-2015-103394. Epub 2015 Nov 6.
Ferrara C, Patel P, Becker S, Stanley CA, Kelly A. Biomarkers of Insulin for the Diagnosis of Hyperinsulinemic Hypoglycemia in Infants and Children. J Pediatr. 2016 Jan;168:212-9. doi: 10.1016/j.jpeds.2015.09.045. Epub 2015 Oct 17.
Kalish JM, Boodhansingh KE, Bhatti TR, Ganguly A, Conlin LK, Becker SA, Givler S, Mighion L, Palladino AA, Adzick NS, DeLeon DD, Stanley CA, Deardorff MA: Persistent congenital hyperinsulinism in children with mosaic paternal 11p uniparental isodisomy and variable features of Beckwith-Wiedemann Syndrome. Journal of Medical Genetics 53:53-61, 2016.
Bhatti TR, Ganapathy K, Huppman AR, Conlin L, Boodhansingh KE, MacMullen C, Becker S, Ernst LM, Adzick NS, Ruchelli ED, Ganguly A, Stanley CA: Histologic and molecular profile of pediatric insulinomas: Evidence of a paternal parent-of-origin effect. Journal of Clinical Endocrinology and Metabolism 101:914-22, 2016.
2014
Tegtmeyer LC, Rust S, van Scherpenzeel M, Ng BG, Losfeld ME, Timal S, Raymond K, He P, Ichikawa M, Veltman J, Huijben K, Shin YS, Sharma V, Adamowicz M, Lammens M, Reunert J, Witten A, Schrapers E, Matthijs G, Jaeken J, Rymen D, Stojkovic T, Laforet P, Petit F, Develaux I, Piraud M, Stanley CA, Matalon R, Burda P, Seyyedi S, Debus V, Socha P, Sykut-Cegielska J, van Spronsen F, de Meirleir L, Vajro P, DeClue T, Ficicioglu C,Wada Y, Wevers RA, Vanderschaeghe D, Callewaert N, Fingerhut R, van Schaftingen E, Freeze HH, Morava E, Lefeber DJ, Marquardt T: Multiple phenotypes in phosphoglucomutase 1 deficiency. New Eng J Med 370(6): 533-42, Feb 2014.
Boodhansingh KE, Cresio A, De Leon DD, Stanley CA: A novel atypical presentation of insulin autoimmune syndrome (Hirata's disease) in a child JPEM 2014 Notes: Accepted for Publication.
2013
Laje P, States LJ, Becker SA, Palladino AA, Stanley CA, Adzick NS: Accuracy of PET/CT Scan in the diagnosis of the focal form of congenital hyperinsulinism. J Pediatr Surg 48(2): 388-93, Feb 2013.
Li C, Liu C, Nissim I, Chen J, Chen P, Doliba N, Zhang T, Nissim I, Daikhin Y, Stokes D, Yudkoff M, Bennett MJ, Stanley CA, Matschinsky FM, Naji A: Regulation of Glucagon Secretion in Normal and Diabetic Human Islets by Gamma-Hydroxybutyrate and Glycine. J Biol Chem 288(6): 3938-51, Feb 2013.
Snider K E, Becker S, Boyajian L, Shyng S-L, Macmullen C, Hughes N, Ganapathy K, Bhatti T, Stanley C A, Ganguly A: Genotype and Phenotype Correlations in 417 Children With Congenital Hyperinsulinism. J Clin Endocrinol Metab 98(2): E355-63, Feb 2013.
Faletra F, Snider K, Shyng SL, Bruno I, Athanasakis E, Gasparini P, Dionisi-Vici, Ventura A, Zhou Q, Stanley CA, Burlina A: Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: Clinical and functional characterization of two novel ABCC8 mutations. Gene 516(1): 122-5, Mar 2013.
Huang T, Kelly A, Becker SA, Cohen MS, Stanley CA: Hypertrophic cardiomyopathy in neonates with congenital hyperinsulinism. Arch Dis Child Fetal Neonatal Ed. 98(4), Jul 2013 Notes: [Epub ahead of print]
Laje P, Palladino AA, Bhatti TR, States LJ, Stanley CA, Adzick NS: Pancreatic surgery in infants with Beckwith-Wiedemann Syndrome and Hyperinsulinism. J Pediatr Surg 48(12): 2511-16, Dec 2013.
Peranteau WH, Palladino AA, Bhatti TR, Becker SA, States LJ, Stanley CA, Adzick NS: The surgical management of insulinomas in children. J Pediatr Surg 48(12): 2517-24, Dec 2013.
Pinney SE, Ganapathy K, Bradfield J, Stokes D, Sasson A, Mackiewicz K, Boodhansingh K, Hughes N, Becker S, Givler S, Macmullen C, Monos D, Ganguly A, Hakonarson H, Stanley CA.: Dominant Form of Congenital Hyperinsulinism Maps to HK1 Region on 10q. Horm Res Paediatr 80(1): 18-27, 2013.
2012
Palladino Andrew A, Chen Jie, Kallish Staci, Stanley Charles A, Bennett Michael J: Measurement of tissue acyl-CoAs using flow-injection tandem mass spectrometry: acyl-CoA profiles in short-chain fatty acid oxidation defects. Mol Genet Metab 107(4): 679-83, Dec 2012.
Calabria AC, Li C, Gallagher PR, Stanley CA, De León DD. GLP-1 Receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel. Diabetes. Epub 2012 Aug 1. Cited in PubMed; PMID 22855730.
Stanescu DE, Hughes N, Kaplan B, Stanley CA, De León DD. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab. Epub 2012 Jul 16. Cited in PubMed; PMID 22802087.
Blomberg BA, Moghbel MC, Saboury B, Stanley CA, Alavi A. The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis. Mol Imaging Biol. Epub 2012 Jul 3. Cited in PubMed; PMID 22752652.
Narayan SB, Master SR, Sireci AN, Bierl C, Stanley PE, Li C, et al. Short-chain 3-hydroxyacyl-coenzyme A dehydrogenase associates with a protein super-complex integrating multiple metabolic pathways. PLoS One. 2012;7(4):e35048. Epub 2012 Apr 9. Cited in PubMed; PMCID: PMC3322157.
Laje P, Stanley CA, Palladino AA, Becker SA, Adzick NS. Pancreatic head resection and Roux-en-Y pancreaticojejunostomy for the treatment of the focal form of congenital hyperinsulinism. J Pediatr Surg. 2012 Jan;47(1):130-5. Cited in PubMed; PMID 22244405.
Doliba NM, Qin W, Najafi H, Liu C, Buettger CW, Sotiris J, et al. Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics. Am J Physiol Endocrinol Metab. 2012 Jan 1;302(1):E87-E102. Epub 2011 Sep 27. Cited in PubMed; PMID 21952036.
Books
Charles A. Stanley and Diva D. De Leon (Eds): Monogenic Hyperinsulinemic Hypoglycemia Disorders. Frontiers in Diabetes. Karger, 21, Feb 2012.
Editorials, Reviews, Chapters
2014
De León DD, and Stanley CA: Permanent Neonatal Diabetes Mellitus. GeneReview. Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K (eds.). GeneReviews™ [Internet]. Updated, Jan 23 2014.
2013
Blomberg BA, Moghbel MC, Saboury B, Stanley CA, Alavi A.: The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis. Mol Imaging Biol 15(1): 97-105, Feb 2013.
De Leon DD, Stanley CA: Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemia. Best Practice & Research Clinical Endocrinology & Metabolism 27(6): 763-769, Dec 2013.
De Leon DD, Thornton PS, Stanley CA, Sperling MA: Hypoglycemia in Neonates and Infants. Pediatric Endocrinology, 4th Edition. Mark A. Sperling (eds.). Saunders, 2013.
De Leon DD, Stanley CA: Hypoglycemia. Contemporary Endocrinology. Sally Radovick (eds.). Springer, 2013.
Kelly A, Stanley CA: Hyperinsulinism. Pediatric Endocrinology and Inborn Errors of Metabolism, 2nd Edition. Sarafoglou K, Roth KS, Hoffmann GF (eds.). 2013.
Langdon DR, Stanley CA, Sperling MA.: Hypoglycemia in the Infant and Child. Pediatric Endocrinology, 4th Edition. Mark A. Sperling (eds.). Saunders, 2013.
Stanley CA: Congenital Hyperinsulinism. Clinical Decision Support: Pediatrics. Bonney, McMillan, Barrett, Jones (eds.). Decision Support in Medicine, LLC, 2013 Notes: online publication.
Stanley CA, Palmieri F, Bennett MJ: Disorders of the Mitochondrial Carnitine Shuttle. Online Molecular and Metabolic Basis of Inherited Disease. Valle D, Vogelstein B, Kinzler KW, Antonarakis SE, Ballagio A, Gibson KM, Mitchell G (eds.). McGraw Hill, Part 10:2013, 2013.
2012
Stanley CA, Matschinsky FM. Historical perspective on the genetic forms. In: Stanley CA, De Leon DD, editors. Monogenic hyperinsulinemic hypoglycemia disorders. Basel (Switzerland): S. Karger AG; 2012. p. 1-6. (Frontiers in diabetes; vol. 21).
Sayed S, Matschinsky FM, Stanley CA. Hyperinsulinism due to activating mutations of glucokinase. In: Stanley CA, De Leon DD, editors. Monogenic hyperinsulinemic hypoglycemia disorders. Basel (Switzerland): S. Karger AG; 2012. p. 146-57. (Frontiers in diabetes; vol. 21).
Li C, Matschinsky FM, Stanley CA. Amino acid-stimulated insulin secretion: the role of the glutamine-glutamate-alpha-ketoglutarate axis. In: Stanley CA, De Leon DD, editors. Monogenic hyperinsulinemic hypoglycemia disorders. Basel (Switzerland): S. Karger AG; 2012. p. 112-124. (Frontiers in diabetes; vol. 21).
Kelly A, Palladino A, Stanley CA. Congenital hyperinsulinism due to activating mutations of glutamate dehydrogenase: the hyperinsulinism/hyperammonemia syndrome. In: Stanley CA, De Leon DD, editors. Monogenic hyperinsulinemic hypoglycemia disorders. Basel (Switzerland):S. Karger AG; 2012. p. 100-11. (Frontiers in diabetes; vol. 21).
De Leon DD, Stanley CA:. Pathophysiology of diffuse ATP-sensitive potassium channel hyperinsulinism. In: Stanley CA, De Leon DD, editors. Monogenic hyperinsulinemic hypoglycemia disorders. Basel (Switzerland): S. Karger AG; 2012. p. 18-29. (Frontiers in diabetes; vol. 21).
2011
Stanley CA, Bennett MJ. Disorders of mitochondrial fatty acid beta-oxidation. In: Kliegman RM, Stanton BF, St. Geme III JW, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier Saunders; 2011. p. 456-62.
Hardy OT, Stanley CA. Hypoglycemia. In: Polin RA, Fox, WW, Abman SH, editors. Fetal and neonatal physiology: expert consult. Philadelphia: Elsevier Health Sciences Division; 2011. p. 568-75.
DeLeon D, Stanley CA. Hypoglycemia. In: Radovick S, MacGillivray MH, editors. Pediatric endocrinology: a practical clinical guide. 2nd ed. New York: Springer; 2011.
2008
Kelly A, Stanley CA. Hyperinsulinism. In: Sarafoglou K, editor. Pediatric endocrinology and inborn errors of metabolism. New York: McGraw Hill; 2008. p. 39-50.
2007
Stanley CA, Bennett MJ. Disorders of mitochondiral fatty acid oxidation. In: Kliegman RM, Behrman RE, Jenson HB, Stanton B, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: Saunders Elsevier; 2007. p. 567-72.
2006
Stanley CA, Bennett MJ, Mayatepek E. Disorders of mitochondrial fatty acid oxidation and related metabolic pathways. In: Fernandes J, Saudubray JM, van den Berghe G, Walter JH, editors. Inborn metabolic diseases: diagnosis and treatment. 4th ed. Heidelberg (Germany): Springer Medizin Verlag; 2006. p. 175-90.
Hardy OT, Stanley CA. Hyperinsulinism of infancy: localization of focal forms. In: Charron M, editor. Practical pediatric PET imaging. New York: Springer; 2006. p. 479-84.
DeLeon DD, Stanley CA. When to screen for neonatal hypoglycemia. In: Wildschut H, Weiner CP, Peters TJ, editors. When to screen in obstetrics and gynecology. 2nd ed. Philadelphia: Saunders Elsevier; 2006. p. 483-90.
2005
Katz LL, Stanley CA. Disorders of glucose and other sugars. In: Spitzer AR, editor. Intensive care of the fetus & neonate. 2nd ed. Philadelphia: Elsevier, Inc.; 2005. p.1167-78.
2004
Stanley CA, Pallotto EK. Disorders of carbohydrate metabolism. In: Taeusch HW, Ballard RA, Gleason CA, editors. Avery's diseases of the newborn. 8th ed. Philadelphia: WB Saunders; 2004. p. 1410-22.
Stanley CA. Hypoglycemia. In: Kleigman RN, Greenbaum LA, Lye PS, editors. Practical strategies in pediatric diagnosis and therapy. 2nd ed. Philadelphia: Elsevier Saunders ; 2004. p. 1121-31.
Kelly A, Changhong L, Stanley CA. Glucokinase/glutamate dehydrogenase interactions in the GDH form of congenital hyperinsulinism. In: Matschinsky FM, Magnuson MA, editors. Glucokinase and glycemic disease: from basics to novel therapeutics. Basel (Switzerland): S. Karger AG; 2004. p. 110-24. (Frontiers in Diabetes; vol. 16).
2003
Stanley CA, Caplin N. Pathophysiology of hypoglycemia. In: Polin R, Fox W, Abman S, editors. Fetal and neonatal physiology. 3rd ed. Philadelphia: WB Saunders; 2003. p. 494-99.
Stanley CA. Hypoglycemia. In: Radovick S, MacGillivray MH, editors. Pediatric endocrinology: a practical clinical guide. Totowa (NJ): Humana Press Inc.; 2003. p. 511-21.
2002
Thornton PA, Finegold DN, Stanley CA. Hypoglycemia in the infant and child. In: Sperling MA, editor. Pediatric endocrinology. Philadelphia: WB Saunders; 2002. p. 367-84.
Stanley, CA, Thornton, PS, Finegold, DN, Sperling, MA. Hypoglycemia in neonates and infants. In: Sperling MA, editor. Pediatric endocrinology. Philadelphia: WB Saunders; 2002. p. 135-159.
2000
Stanley CA. Disorders of fatty acid oxidation. In: Fernandes J, Saudubray JM, van den Berghe G, editors. Inborn metabolic diseases. 3rd ed. Heidelberg: Springer-Verlag; 2000. p. 139-50, 2000.
Stanley CA. Hypoglycemia. In: Stockman JA, Lohr JA, editors. Essence of office pediatrics. Philadelphia: WB Saunders; 2000. p. 213.
Stanley CA. Lethargy and vomiting in a 14 month-old boy. In: Burg FD, Vaughan VC, Nelson KG, editors. Pediatrics: a problem-based review. Philadelphia: W.B. Saunders Company; 2000. p. 232-35.
Stanley CA. Disorders of carbohydrate metabolism. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, editors. Pediatric gastrointestinal disease. Philadelphia: Decker; 2000.
1999
Stanley CA. The hyperinsulinism-hyperammonemia syndrome: gain-of-function mutations of glutamate dehydrogenase. In: O'Rahilly S, Dunger DB, editors. Genetic insights in pediatric endocrinology and metabolism. Bristol (UK): BioScientifica, Ltd.; 1999. p. 23-30.
Satin-Smith MS, Stanley CA. Hypoglycemia. In: Burg FD, Ingelfinger JR, Wald ER, Polin RA, editors. Gellis and Kagan's current pediatric therapy. 16th ed. Philadelphia: W.B. Saunders; 1999. p. 772-74.
1998
Stanley CA. Defects in metabolism of lipids. In: Behrman RE, Kliegman RM, Jenson HB, editors. Nelson Textbook of Pediatrics. 16th ed. Philadelphia: Saunders; 1998.
Stanley CA. Defects in metabolism of lipids. In: Altschuler S, Ludwig S, editors. Endocrinology. McGraw-Hill Publishing; 1998. Chapter 72, 90, 94, 96, 98 Pediatrics at a Glance, 1998.
Stanley CA. Neonatal carnitine metabolism. In: Cowett RM, editor. Principles of neonatal metabolism. 2nd ed. New York: Springer Verlaq; 1998.
Nestorowicz A, Stanley CA, Landau H, Glaser B, Permutt MA. Familial hyperinsulinism in Ashkenazi Jews. In: Desnick RJ, editor. Advances in Jewish genetic diseases. New York: Oxford University Press;1998.
1995
Katz L, Stanley CA. Disorders of glucose and other sugars. In: Spitzer AR, editor. Intensive care of the fetus and neonate. Philadelphia: Mosby - Yearbook; 1996. p. 982-92.
Stanley CA. Carnitine/acylcarnitine translocase deficiency. In: Neurobase. Arbor Publishing Company; 1995.
Stanley CA: Carnitine palmitoyl transferase-1 (CPT-1) deficiency. In: Neurobase. Arbor Publishing Company; 1995.
Stanley CA: Medium-chain acyl-CoA dehydrogenase deficiency. In: Neurobase. Arbor Publishing Company; 1995.
1994
Stanley CA. Disorders of fatty acid oxidation. In: Fernandes J, Saudubray JM, Van Den Berghe T, editors. Inborn metabolic diseases: diagnosis and treatment. 2nd ed. Berlin (Germany): Springer-Verlag; 1994. p. 133-43.
Stanley CA. Defects in metabolism of lipids: disorders of mitochondrial fatty acid oxidation. In: Behrman RE, Kliegman RM, Arvin AM, Nelson WE, editors. Nelson's textbook of pediatrics. 15th ed. Philadelphia: WB Saunders; 1994. p. 360-63.
1992
Thornton PS, Berry GT, Stanley CA. Disorders of intermediary metabolism: organ system failure. In: Holbrook P, editor. Pediatric critical care; 1992. p. 725-40.
Stanley CA. Disorders of fatty acid oxidation. In: Nelson's textbook of pediatrics. 14th ed. Philadelphia: W.B. Saunders; 1992. p. 336-38.
1991
Stanley CA. Disorders of carbohydrate metabolism. In: Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, editors. Pediatric gastrointestinal disease: pathophysiology, diagnosis, management. Philadelphia: BC Decker; 1991. p. 936-43.
Stanley CA: Neonatal carnitine metabolism. In: Cowett RM, editor. Principles of neonatal metabolism. New York: Springer Verlag; 1991. p. 465-71.
1990
Stanley CA: Disorders of fatty acid oxidation. In: Fernandes J, Bremer E, Saudubray JM, editors. Inborn metabolic diseases: diagnosis and treatment. New York: Springer Verlag; 1990. p. 394-410.
Marx B, Stanley CA. Diabetes mellitus. In: Schwartz MW, Charney EB, Curry TA, Ludwig S, editors. Pediatric primary care. Chicago: Yearbook Medical Publishers; 1990. p. 423-29.
1987
Stanley CA. A 3-month old infant with a seizure. In: Clini-Pearls New York: Creative Medical Publications, Inc.; 1987. p. 1-4.
Marx B, Stanley CA. Diabetes. In: Schwartz MW, Ludwig S, Curry TA, Charney EB, editors. Principles and practice of clinical pediatrics. Chicago: Yearbook Medical Publishers; 1987. p. 348-54.
1985
Stanley CA. Intragastric feeding in glycogen storage disease and other disorders of fasting. In: Walker WA, Watkins JB, editors. Nutrition in pediatrics. Boston: Little, Brown & Co; 1985. p. 781-94.
1978
Stanley CA, Baker L. Hypoglycemia. In: Kaye R, Oski F, Barness L, editors. Core textbook of pediatrics. Philadelphia: J.B. Lippincott Co.; 1978; p. 280-305.
Baker L, Stanley CA. Diabetes in childhood. In:DeGroot l, Winegrad AI, editors. Endocrinology metabolic basis of clinical practice. New York: Grune and Stratton; 1978. p. 1057-60.
1977
Baker L, Stanley CA. Hyperinsulinism in infancy: a patho-physiologic approach to diagnosis and treatment. In: Chiumello G, editor. Rec Prog Pediatr Endocrinol. New York: Academic Press; 1977. p. 89-100.